Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-22-3p
|
MIMAT0000077 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_41926791 Show fit | 3.42 |
ENST00000291232.5
|
TNF receptor superfamily member 13C |
|
chr9_+_122371014 Show fit | 2.05 |
ENST00000362012.7
|
prostaglandin-endoperoxide synthase 1 |
|
chr1_-_212699817 Show fit | 2.03 |
ENST00000243440.2
|
basic leucine zipper ATF-like transcription factor 3 |
|
chr1_+_192809031 Show fit | 2.01 |
ENST00000235382.7
|
regulator of G protein signaling 2 |
|
chr11_-_75351609 Show fit | 1.98 |
ENST00000420843.7
|
arrestin beta 1 |
|
chr7_+_128937917 Show fit | 1.87 |
ENST00000357234.10
ENST00000613821.4 ENST00000477535.5 ENST00000479582.5 ENST00000464557.5 ENST00000402030.6 |
interferon regulatory factor 5 |
|
chr9_+_36136416 Show fit | 1.64 |
ENST00000396613.7
|
GLI pathogenesis related 2 |
|
chr22_-_38872206 Show fit | 1.49 |
ENST00000407418.8
ENST00000216083.6 |
chromobox 6 |
|
chr1_-_17439657 Show fit | 1.47 |
ENST00000375436.9
|
regulator of chromosome condensation 2 |
|
chr1_+_52404591 Show fit | 1.43 |
ENST00000257181.10
|
pre-mRNA processing factor 38A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 2.8 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 2.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 2.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 2.2 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 2.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 2.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 1.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 1.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 1.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.9 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 1.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 1.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 1.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 2.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.7 | 2.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.0 | 1.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 1.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 1.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 2.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 2.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 2.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 2.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |